MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Clinical, motor and global cognition in patients with in early stages of Parkinson disease

    J. Orozco, J. Valderrama, Y. Castaño, J. Arango, A. Navarro, B. Muñoz (Cali, Colombia)

    Objective: To explore if balance and freezing of gait correlate with global cognition in patients with Parkinson disease in early stages. Background: Early alterations in…
  • 2019 International Congress

    Task difficulty and the three-stimulus oddball task in patients with PD

    E. Peterson, R. Shoorangiz, R. Jones, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, R. Kuijer, T. Anderson, J. Dalrymple-Alford, B. Elias (Auckland, New Zealand)

    Objective: Examine the effect of task difficulty on event-related potentials (ERPs) in an oddball task in patients with PD. Background: In three-stimulus oddball tasks, some…
  • 2019 International Congress

    Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings

    A. Petit, A. Lackmy, R. Edragas, S. Belson, A. Mongis-Marlin, C. Stattner, F. Triboulet, G. Lepage, B. Tressieres, B. Gaymard, A. Lannuzel (Fort de France, Martinique)

    Objective: To analyze the cognitive profile of patients with degenerative parkinsonian syndromes in the French West Indies and explore the correlations between cognitive deficits and…
  • 2019 International Congress

    Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

    D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

    Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the current Movement Disorder Society (MDS) diagnostic standards for Mild Cognitive Impairment…
  • 2019 International Congress

    Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?

    R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To determine the frequency and impact of cognitive complaints in Parkinson’s disease (PD) patients with normal cognition (NC). Background: PD patients are at a…
  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • 2019 International Congress

    Synuclein-alpha´s variant, rs 894280 shows association with memory and attention in PD patients

    O. Monchi, JR. Sarna, D. Martino, Z. Gan-Or, JA. Ruskey, T. Alrazi, A. Robichaud, T. Hammer, ST. Lang, J. Cheetham, E. Yoon, M. Kibreab, I. Kathol, JS. Provost, M. Ramezani (Calgary, AB, Canada)

    Objective: To assess the effect of rs894280 of Sybnuclein-alpha (SNCA)gene on cognitive profile of idiopathic Parkinson’s disease (PD) patients and patterns of neuronal activity during a set-shifting…
  • 2019 International Congress

    Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.

    TZ. Ren, K. Nie, LJ. Wang (Guangzhou, China)

    Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…
  • 2019 International Congress

    Spoken Language Profiles in Parkinson’s Disease: A Potential ‘Biomarker’ of Cognitive Change?

    A. Roberts (Evanston, IL, USA)

    Objective: To Investigate the differences in spoken language profiles of individuals with Parkinson’s disease (PD) compared to healthy controls (HC). Background: In the absence of…
  • 2019 International Congress

    Measuring cognitive decline in PD-MCI patients with high level education: Do we have the appropriate tools?

    L. Mentzer, A. Richardson, T. Nevo, S. Meyer, S. Rosenblum, N. Gemerman, S. Hassin-Baer, S. Israeli-Korn, T. Fay-Karmon, V. Livneh, G. Yahalom (Ramat-Gan, Israel)

    Objective: To explore cognitive, neuropsychological and daily functional-related cognitive deficits among PD patients, diagnosed with mild cognitive impairment (MCI). Background: Level I diagnostic criteria for…
  • « Previous Page
  • 1
  • …
  • 1351
  • 1352
  • 1353
  • 1354
  • 1355
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley